These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6139655)

  • 1. Controversy about alpha 1-antitrypsin in bronchoalveolar lavage fluids.
    Stockley RA; Burnett D
    Lancet; 1983 Dec; 2(8362):1311. PubMed ID: 6139655
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proteins in bronchoalveolar lavage fluid].
    Hayem A
    Ann Biol Clin (Paris); 1982; 40(3):231-3. PubMed ID: 6753654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concentration of leukocyte elastase-alpha 1-proteinase inhibitor complex in bronchoalveolar lavage fluids from healthy human subjects.
    Jochum M; Pelletier A; Boudier C; Pauli G; Bieth JG
    Am Rev Respir Dis; 1985 Oct; 132(4):913-4. PubMed ID: 3876796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of various immunobiochemical indicators in the serum and bronchoalveolar washings of patients with bronchiectasis and atopic asthma].
    Płusa T; Raczka A; Kruszewski J; Wasek Z
    Pneumonol Pol; 1984 Sep; 52(9):435-40. PubMed ID: 6085153
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid.
    Cochrane CG; Spragg R; Revak SD
    J Clin Invest; 1983 Mar; 71(3):754-61. PubMed ID: 6600748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum angiotensin-converting enzyme and bronchoalveolar lavage in sarcoidosis.
    Stanislas-Leguern G; Marsac J; Arnoux A; Lecossier D
    Lancet; 1979 Mar; 1(8118):723. PubMed ID: 85959
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects.
    Olsen GN; Harris JO; Castle JR; Waldman RH; Karmgard HJ
    J Clin Invest; 1975 Feb; 55(2):427-30. PubMed ID: 1079211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of nitrogen dioxide exposure on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid of normal subjects.
    Mohsenin V; Gee JB
    Am Rev Respir Dis; 1987 Sep; 136(3):646-50. PubMed ID: 3498415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxalic acid level in bronchoalveolar lavage fluid from patients with invasive pulmonary aspergillosis.
    Benoit G; Feuilhade de Chauvin M; Cordonnier C; Astier A; Bernaudin JF
    Am Rev Respir Dis; 1985 Oct; 132(4):748-51. PubMed ID: 4051310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral components of bronchoalveolar lavage in the sheep.
    Rola-Pleszczynski M; Sirois P; Bégin R
    Lung; 1981; 159(2):91-9. PubMed ID: 7230883
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute effect of smoking on the functional activity of alpha1-protease inhibitor in bronchoalveolar lavage fluid.
    Abboud RT; Fera T; Richter A; Tabona MZ; Johal S
    Am Rev Respir Dis; 1985 Jan; 131(1):79-85. PubMed ID: 3871315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary sarcoidosis: value of bronchoalveolar lavage for therapeutic indications].
    Perrin-Fayolle M; Harf R; Biot N; Chevalier JP; Montagnon B
    Nouv Presse Med; 1980 Jan; 9(3):185. PubMed ID: 7355101
    [No Abstract]   [Full Text] [Related]  

  • 13. Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors.
    Afford SC; Stockley RA; Kramps JA; Dijkman JH; Burnett D
    Anal Biochem; 1985 Nov; 151(1):125-30. PubMed ID: 3853960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylene blue decreases the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage.
    Richter AM; Abboud RT; Johal SS
    Am Rev Respir Dis; 1986 Aug; 134(2):326-7. PubMed ID: 3488702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic bronchoalveolar lavage and the study of the lipid fractions of the alveolar content in tuberculosis].
    Filippov VP; Zalesskaia IuM; Tarkovskaia NE
    Probl Tuberk; 1981 Apr; (4):54-7. PubMed ID: 6894795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of protease inhibitors on the anti-enzymatic and surface activities of bronchoalveolar contents in infectious-toxic shock].
    Protsenko VA; Opryshko VV; Shpak SI; Nesterov EN; Safronova LG
    Patol Fiziol Eksp Ter; 1984; (6):49-52. PubMed ID: 6084229
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in protease inhibitor balance of the bronchoalveolar secretion in children with inflammatory lung diseases].
    Bogadel'nikov IV; Kubyshkin AV; Gavalova NG
    Pediatriia; 1990; (3):17-20. PubMed ID: 2385464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the elastase: alpha 1-antitrypsin balance in patients with bacterial pneumonia using bronchoalveolar lavage].
    Fujita J; Bungo M; Hata Y; Nakamura H; Shiotani T; Irino S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):712-7. PubMed ID: 2796064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome.
    Parsons PE; Fowler AA; Hyers TM; Henson PM
    Am Rev Respir Dis; 1985 Sep; 132(3):490-3. PubMed ID: 4037522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on broncho-alveolar-lavage-fluid in sarcoidosis--the protein components (author's transl)].
    Ichimura K; Takada K; Sugiura T; Morishita M; Torii Y; Aoki H; Ina Y; Suzuki M; Yamamoto M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Feb; 20(2):164-9. PubMed ID: 7098180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.